Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-22-000302
Filing Date
2022-08-12
Accepted
2022-08-12 15:30:12
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. - FORM 10-Q SEC FILING rtsl-20220630.htm   iXBRL 10-Q 592951
2 CERTIFICATION rtsl_ex311.htm EX-31.1 6686
3 CERTIFICATION rtsl_ex312.htm EX-31.2 6697
4 CERTIFICATION rtsl_ex321.htm EX-32.1 3541
5 CERTIFICATION rtsl_ex322.htm EX-32.2 3649
11 IMAGE rtsl10q_1.jpg GRAPHIC 5735
  Complete submission text file 0001393905-22-000302.txt   2853500

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtsl-20220630_cal.xml EX-101.CAL 21694
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtsl-20220630_def.xml EX-101.DEF 82599
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rtsl-20220630_lab.xml EX-101.LAB 162858
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtsl-20220630_pre.xml EX-101.PRE 154619
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtsl-20220630.xsd EX-101.SCH 32177
57 EXTRACTED XBRL INSTANCE DOCUMENT rtsl-20220630_htm.xml XML 286379
Mailing Address 15800 DOOLEY RD. SUITE 200 ADDISON TX 75001
Business Address 15800 DOOLEY RD. SUITE 200 ADDISON TX 75001 800-497-6059
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

EIN.: 462111820 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55018 | Film No.: 221159694
SIC: 2834 Pharmaceutical Preparations